Low arterial saturation is associated with increased sensitivity to activated protein C in children with congenital heart disease

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 20, Issue 1, 2006, Pages 38-42

  Sambasivan, Arathi ^a   Tibble, Adam ^b   Donahue, Brian S ^b,c  

^a LANKENAU HOSPITAL   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Activated protein C; Blood; Coagulation; Congenital heart disease; Cyanosis; Genetics

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8;

ADOLESCENT; ARTERIAL OXYGEN SATURATION; ARTICLE; CHILD; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEART CATHETERIZATION; HETEROZYGOSITY; HUMAN; HYPOXEMIA; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ANOXEMIA; CHILD; CHILD, PRESCHOOL; FACTOR V; FACTOR VIII; FEMALE; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROTEIN C; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 31844444716     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2005.03.025     Document Type: Article

References (27)

1. D.K. Tempe, S. Virmani Coagulation abnormalities in patients with cyanotic congenital heart disease J Cardiothorac Vasc Anesth 16 2002 752 765
2. J. Petaja, K. Peltola, H. Sairanen Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations J Thorac Cardiovasc Surg 112 1996 665 671
3. J. Petaja, U. Lundstrom, H. Sairanen Central venous thrombosis after cardiac operations in children J Thorac Cardiovasc Surg 112 1996 883 889
4. G.D. Williams, S.L. Bratton, E.C. Riley Association between age and blood loss in children undergoing open heart operations Ann Thorac Surg 66 1998 870 876
5. F. Fukumura, A. Sese, Y. Ueno Haemostatic profile of small children during and following cardiopulmonary bypass Jpn J Thorac Cardiovasc Surg 51 2003 577 781
6. C.T. Esmon The protein C pathway Chest 124 suppl 2003 26S 32S
7. P. Clark, I.D. Walker The phenomenon known as acquired activated protein C resistance Br J Haematol 115 2001 767 773
8. A.J. Chong, T.H. Pohlman, C.R. Hampton Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury Ann Thorac Surg 75 suppl 2003 S649 S655
9. J. Petaja, E. Pesonen, J.A. Fernandez Cardiopulmonary bypass and activation of antithrombotic plasma protein C J Thorac Cardiovasc Surg 118 1999 422 431
10. P.M. Ridker, C.H. Hennekens, K. Lindpaintner Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men N Engl J Med 332 1995 912 917
11. L. Breiman, J. Friedman, R. Olshen Classification and Regression Trees 1998 CRC Press Boca Raton, FL
12. S. Koulouri, R.J. Acherman, P.C. Wong Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress Pediatr Cardiol 25 2004 341 346
13. T.S. Mir, S. Marohn, S. Laer Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure Pediatrics 110 2002 e76
14. S.F. Yan, N. Mackman, W. Kisiel Hypoxia/hypoxemia-induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis Arterioscler Thromb Vasc Biol 19 1999 2029 2035
15. S.F. Yan, Y.S. Zou, Y. Gao Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia Proc Natl Acad Sci U S A 95 1998 8298 8303
16. D.J. Pinsky, H. Liao, C.A. Lawson Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition J Clin Invest 102 1998 919 928
17. H.H. Hovels-Gurich, K. Schumacher, J.F. Vazquez-Jimenez Cytokine balance in infants undergoing cardiac operation Ann Thorac Surg 73 2002 601 609
18. G. Le Roux, P. Larmignat, M. Marchal Haemostasis at high altitude Int J Sports Med 13 suppl 1992 S49 S51
19. L.H. Caramuru, P. Soares Rde, N.Y. Maeda Hypoxia and altered platelet behavior influence von Willebrand factor multimeric composition in secondary pulmonary hypertension Clin Appl Thromb Hemost 9 2003 251 258
20. P. Clark, N. Sattar, I.D. Walker The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study Significance of pregnancy associated activated protein C resistance Thromb Haemost 85 2001 30 35
21. L.A. Heinemann, C. Kluft, M. Spannagl The association between extrinsic activated protein C resistance and venous thromboembolism in women Contraception 66 2002 297 304
22. K. Nakanishi, T. Shichijo, G. Kato Risk factors reducing blood transfusion requirements in pediatric open heart surgery after introduction of vacuum assisted circuits Jpn J Thorac Cardiovasc Surg 49 2001 564 569
23. G. Lehmann, C. Schmitt, V. Kehl Electrocardiographic algorithm for assignment of occluded vessel in acute myocardial infarction Int J Cardiol 89 2003 79 85
24. E. Marvez, S.J. Weiss, D.E. Houry Predicting adverse outcomes in a diagnosis-based protocol system for rapid sequence intubation Am J Emerg Med 21 2003 23 29
25. J.W. Salyer Neonatal and pediatric pulse oximetry Respir Care 48 2003 386 398
26. D.K. Richardson, J.E. Gray, M.C. McCormick Score for Neonatal Acute Physiology A physiologic severity index for neonatal intensive care Pediatrics 91 1993 617 623
27. G.B. Segel, C.A. Francis Anticoagulant proteins in childhood venous and arterial thrombosis A review Blood Cells Mol Dis 26 2000 540 560